Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Dec' 25	Sep' 25	Jun' 25	Mar' 25	Dec' 24

Sales

553.63

522.15

498.62

555.96

550.92

Operating profit

81.20

62.22

67.23

67.93

74.10

Interest

27.25

29.41

30.45

29.36

34.21

Gross profit

157.20

46.90

38.54

50.69

42.31

EPS (Rs)

13.23

3.48

1.45

1.75

1.62

Other income

103.24

14.09

1.76

12.12

2.43

Stock adjustment

-0.90

-3.65

15.46

3.30

-47.96

Raw material

255.50

255.66

210.98

268.29

295.26

Power and fuel

-

-

-

-

-

Employee expenses

95.14

96.49

94.04

91.86

93.80

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

122.70

111.43

110.91

124.57

135.72

Provisions made

-

-

-

-

-

Depreciation

22.40

21.51

22.14

22.37

20.92

Taxation

12.91

-6.65

3.06

12.20

6.44

Net profit / loss

121.90

32.04

13.35

16.13

14.94

Extra ordinary item

-

-

-

-

-0.02

Prior year adjustments

-

-

-

-

-

Equity capital

92.16

92.16

92.16

92.16

92.16

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

14.67

11.92

13.48

12.22

13.45

GPM (%)

23.93

8.75

7.70

8.92

7.65

NPM (%)

18.56

5.97

2.67

2.84

2.70